Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : DR-1-55
Catalog No.: PC-49434Not For Human Use, Lab Use Only.
DR-1-55 (DR-155) is a selective STAT3 inhibitor that covalently modifies a cysteine in the SH2 domain of STAT3.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
DR-1-55 (DR-155) is a selective STAT3 inhibitor that covalently modifies a cysteine in the SH2 domain of STAT3.
DR-1-55 reduced the expression of the STAT3 target gene MMP2, also reduced expression of ERBB2 and ERBB3 in devil facial tumor disease (DFTD) cells.
DR-1-55 (10 mg/kg) reduced tumor growth without observed toxicity in xenograft model of DFTD tumor, reduction of pY STAT3 (Figures 5D and 5E) and reduced MMP2 expression, increased the expression of B2M, while STAT3 expression was decreased.
| M.Wt | 806.672 | |
| Formula | C36H28F10N2O6S | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Lindsay Kosack, et al. Cancer Cell. 2019 Jan 14;35(1):125-139.e9.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
